Aspira Women’s Health to Present at the A.G.P. Healthcare Showcase on May 21
May 16, 2024 08:00 ET
|
Aspira Women's Health Inc.
AUSTIN, Texas, May 16, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of...
Aspira Women’s Health Reports First Quarter 2024 Financial Results
May 15, 2024 07:30 ET
|
Aspira Women's Health Inc.
Q1 2024 OvaSuiteSM revenue of $2.2 million and volume of 5,829 units Q1 2024 cash utilization of $4.4 million, a decrease of 22% compared to Q1 2023 Conference Call and Webcast scheduled for today...
UPDATE -- Aspira Women’s Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15
May 08, 2024 08:47 ET
|
Aspira Women's Health Inc.
AUSTIN, Texas, May 08, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of...
Aspira Women’s Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15
May 08, 2024 08:00 ET
|
Aspira Women's Health Inc.
AUSTIN, Texas, May 08, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of...
Aspira Women’s Health Announces Publication of Two OvaWatch Peer-Reviewed Manuscripts
May 07, 2024 08:00 ET
|
Aspira Women's Health Inc.
AUSTIN, Texas, May 07, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of...
Aspira Women’s Health Enhances its Commercial Offering with the Formal Launch of Longitudinal Monitoring Feature of OvaWatch
May 02, 2024 08:00 ET
|
Aspira Women's Health Inc.
AUSTIN, Texas, May 02, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of...
Aspira Women’s Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in California
April 09, 2024 08:00 ET
|
Aspira Women's Health Inc.
AUSTIN, Texas, April 09, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of...
Aspira Women’s Health Reports Fourth Quarter and Full Year 2023 Financial Results
March 28, 2024 07:30 ET
|
Aspira Women's Health Inc.
2023 OvaSuite revenue of $9.2 million, an increase of 15% year-over-year 2023 OvaSuite volume of 23,990 units, an increase of 12% year-over-year Cash utilization declined in both the fourth...
Aspira Women’s Health Announces New Time for its Fourth Quarter and 2023 Year End Earnings Results and Call
March 25, 2024 08:00 ET
|
Aspira Women's Health Inc.
AUSTIN, Texas, March 25, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of...
Aspira Women’s Health to Present at the MedInvest Biotech & Pharma Investor Conference
March 21, 2024 08:00 ET
|
Aspira Women's Health Inc.
AUSTIN, Texas, March 21, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of...